PolyPid (PYPD) Operating Leases (2022 - 2026)
PolyPid (PYPD) posted Operating Leases of $383000.0 for Q1 2026, down 40.8% sequentially from $647000.0 in Q4 2025, and down 63.31% YoY from $1.0 million in Q1 2025.
PolyPid (PYPD) Operating Leases (2022 - 2026) Analysis & Trends
PolyPid has reported Operating Leases for 5 years, with the latest figure at $383000.0 in Q1 2026.
- Quarterly Operating Leases fell 63.31% year-over-year to $383000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $383000.0 (down 63.31% YoY) and the FY2025 annual result came in at $647000.0, down 49.33% from the prior year.
- Operating Leases eased to $383000.0 in Q1 2026 per PYPD's latest filing, from $647000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $1.8 million in Q1 2024 and troughed at $383000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $1.0 million in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2026: Operating Leases jumped 70.85% in 2024, then slumped 63.31% in 2026.
- Over 5 years, Operating Leases stood at $1.2 million in 2022, then declined by 26.94% to $857000.0 in 2023, then surged by 49.01% to $1.3 million in 2024, then tumbled by 49.33% to $647000.0 in 2025, then plunged by 40.8% to $383000.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $383000.0, $647000.0, and $829000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PolyPid | 113.86 Mn | 107.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 282,000.00 |
| Mar 31, 2026 | 383,000.00 |
| Dec 31, 2025 | 647,000.00 |
| Sep 30, 2025 | 829,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 857,000.00 |
| Sep 30, 2023 | 832,000.00 |
| Jun 30, 2023 | 933,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.17 Mn |